11"x17" - Sanford-Burnham Medical Research Institute

6th Annual Sanford-Burnham Rare Disease Day Symposium
Treating Disease with Sugars
February 27 - 28, 2015 | 10905 Road to the Cure, San Diego CA 92121
Scientific
Symposium
Simple sugars can treat patients
with rare diseases, but these
supplements can also impact
aging, immune function, cancer
and development of diabetes.
Clinical trials are underway, but
the underlying basic science
remains obscure.
February 27, 2015
9:00 am - 5:00 pm
Participate either in person
or online.
“Doctor-is-in”
Session
Our program covers all of these
areas and our speakers will
offer some explanations.
Clinicians, patients, and their
advocates are invited to join
bench scientists, present data,
explore mysteries, advance
theories and offer hope. Join us.
February 28, 2015
9:00 am - 1:00 pm
Interact with researchers and
clinicians in an intimate,
collaborative environment.
N-acetylglucosamine: a Potential Therapy for
Multiple Sclerosis
Keeping it Sweet: Treatment Options for GNE
Myopathy
Michael Demetriou, M.D., Ph.D.
May Christine Malicdan, M.D., Ph.D.
Neurology School of Medicine, University of California, Irvine
National Center for Neurology and Psychiatry, NIH
Hexosamine Pathway Activation Improves
Protein Quality Control and Extends Lifespan
Mannose: Healer and Destroyer
Martin Denzel, Ph.D.
Sanford-Burnham Medical Research Institute
Max Planck Institute for Biology of Ageing
The Double Edged Sword of Nutrient Regulation
of Protein Function by a Sugar
Gerald (Jerry) Hart, Ph.D.
Hudson Freeze, Ph.D.
Nothing to Sneeze at: the Emerging Role of
Sugars in Allergic Syndromes
Jonathan Lyons, M.D.
Laboratory of Allergic Diseases, NIAID/NIH
Johns Hopkins University School of Medicine
Letting Go While Holding On
Jennifer Yashari, M.D.
Testing the Waters: Using Zebrafish as a Tool to
Study Mechanisms Underlying a Glycosylation
Disorder
Neuromuscular Disease Foundation
Jamie Chu, M.D.
Safety and Efficacy Data from a Randomized,
Controlled Phase 2 Study (Including Long-Term 2
Year Data) of Sialic Acid Extended Release in
patients with GNE Myopathy
Mount Sinai’s Recanati/Miller Transplantation Institute
Sunil Agarwal, M.D.
Fucose: Targeting Melanoma with Sugar
Eric Lau, Ph.D.
Sanford-Burnham Medical Research Institute
Ultragenyx Pharmaceutical
Advancing ManNAc as a Therapy for
GNE Myopathy
Nuria Carrillo-Carrasco, M.D.
National Center for Advancing Translational Sciences, NIH
Registration and symposium updates
sanfordburnham.org/rarediseaseday